Patients & Volunteers Information for those interested or currently participating in a clinical trial
	Research Sponsors Why you should choose Aurora for your clinical trials
	Investigators & Coordinators Learn more about our services
	Research Matters Quarterly newsletter about research at Aurora
	Links Learn more about clinical research
	Contact us Contact the Clinical Research department
	Return home Return to the Clinical Research home page

Select from the search options to widen or narrow the search results.

Early  Lung Cancer Screening Study (I-ELCAP)

Early detection can save your life, or the life of someone you love.Consider participating in the International Early Lung Cancer Action Program (IELCAP) study.

For Your information:

Lung cancer is among the most preventable cancers, as tobacco use is responsible for the majority of the lung cancer cases. If detected early and surgically removed, lung cancer has a cure rate of nearly 70%. Without early treatment the long-term survival rate for lung cancer is 15%.

• Lung cancer is the leading cause of cancer death in the United States.
  
• Tobacco is responsible for about 21% of all cancers.
  
• Tobacco is associated with 87% of cancers of the lung.
  
• Routine chest X-rays detect just 15% of early lung cancers.In the year 2000, over 7,000 Wisconsin residents died from
  smoking-related disease.

Aurora St. Luke's Medical Center Lung Cancer Program is now offering a lung screening study using Computed Tomography.

Individuals must meet certain criteria and have had no prior history of cancer.

For more information or to register, please call Lisa Bray, RN, Lung Cancer Program Coordinator at (414) 649-6691.or lisa.bray@aurora.org

Clinical trial location(s)

[ previous page ]

Copyright Aurora Health Care, a not-for-profit health care provider serving Wisconsin.
3000 W. Montana St., Milwaukee, WI 53215, (414) 647-3000
Disclaimer | Privacy notice | Contact us
.